Look in

Intake of  aspirin  and omega-3 is safe and effective at reducing chances of bowel  cancer  in high-risk patients, according to a new clinical trial. In the trial, published in the journal The Lancet, these low-cost drugs reduced the number of pre-cancerous polyps -- a small growth, usually benign -- in patients found to be at high risk of developing bowel cancer. The findings showed that patients who took aspirin had 22 per cent fewer polyps compared to those who took the  placebo . Those who took omega-3, also called EPA (eicosapentaenoic acid) had 9 per cent fewer polyps compared to those who took the placebo. Although aspirin and EPA had beneficial effects on polyp numbers individually, the combination of aspirin and EPA together appeared to have an even greater effect, as it provided another layer of prevention, alongside colonoscopy, the researchers said. "The trial demonstrates that both aspirin and EPA have preventative effects, which is particul...